Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs
Apr 24, 2017 11:01 am UTC| Business
PHOENIX, April 24, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced that effective today, Dr. Steven James will join the Company as Vice President of Medical Affairs. “Dr. James...
Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs
Apr 24, 2017 11:01 am UTC| Business
PHOENIX, April 24, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced that effective today, Dr. Steven James will join the Company as Vice President of Medical Affairs. “Dr. James...
Apr 24, 2017 11:01 am UTC| Business
BOSTON, April 24, 2017 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...
Apr 24, 2017 11:01 am UTC| Business
BOSTON, April 24, 2017 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...
Apr 24, 2017 11:01 am UTC| Business
- Microbiology analysis and full results of Phase 3 OASIS study presented at ECCMID 2017 - Data on utility in geographic regions also presented VIENNA, Austria, April 24, 2017 -- Paratek Pharmaceuticals, Inc....
Apr 24, 2017 11:01 am UTC| Business
- Microbiology analysis and full results of Phase 3 OASIS study presented at ECCMID 2017 - Data on utility in geographic regions also presented VIENNA, Austria, April 24, 2017 -- Paratek Pharmaceuticals, Inc....
Capital City Bank Group, Inc. Reports First Quarter 2017 Results
Apr 24, 2017 11:01 am UTC| Business
TALLAHASSEE, Fla., April 24, 2017 -- Capital City Bank Group, Inc. (Nasdaq:CCBG) today reported net income of $2.7 million, or $0.16 per diluted share for the first quarter of 2017 compared to net income of $3.3...
Tariff Tremors: Trump’s Greenland Fight Rattles Global Markets